Medical Cement Shortage: Hip & Knee Replacements Delayed | NHS Supply Issues

A global supply issue with bone cement, a critical material used in joint replacement surgeries, is prompting concerns about potential delays in care for thousands of patients in the UK. Hospitals have been instructed to prioritize trauma and urgent care cases, potentially impacting those awaiting planned hip and knee replacements.

The disruption stems from a packaging fault at the German manufacturing facility of Heraeus Medical, the primary supplier of bone cement to the National Health Service (NHS). Production at the site has been temporarily halted, with officials estimating a potential supply gap of six to eight weeks. While hospitals currently have approximately two weeks of supply on hand, the situation is being closely monitored.

Bone cement plays a vital role in orthopedic procedures. It’s used to anchor artificial joints securely within the bone, filling the space between the implant and the patient’s natural bone structure. Beyond hip and knee replacements, it’s also utilized in various other surgeries, including some orthopedic and dental procedures.

NHS England has issued guidance to hospitals, directing them to ensure available supplies are allocated to trauma and urgent care situations. The guidance also encourages the exploration of alternative suppliers and a prioritization of orthopaedic waiting lists based on individual patient needs. An NHS England spokesperson stated that any existing hospital stock is unaffected and that they are “working closely with government and leading professional bodies to ensure safe and effective care can be provided while supply is resolved and to reduce delays for patients requiring less urgent care as far as possible.”

The impact of this shortage is particularly concerning given the already substantial waiting lists for joint replacement surgery in England. Currently, an estimated 850,000 patients are awaiting planned treatment for their joints – the largest category of any specialty. The delays will disproportionately affect those experiencing significant pain and reduced mobility, potentially impacting their quality of life.

Campaigners have expressed deep concern for patients already facing lengthy waits. Deborah Alsina, chief executive of Arthritis UK, described the news as a “crushing blow” for individuals who had finally reached the top of the surgical waiting list. She emphasized the importance of clear communication from hospitals to affected patients to minimize anxiety and uncertainty. Arthritis UK is offering support through its free helpline and online community.

Age UK has also voiced concerns, noting that many older patients with scheduled operations may face unavoidable postponements. Caroline Abrahams, charity director at Age UK, expressed hope that the NHS will be able to reschedule surgeries swiftly once the supply issues are resolved and that patients will receive the necessary support to manage their pain in the interim.

Health leaders are committed to minimizing the disruption and directing current supplies to the areas of greatest need. Rory Deighton, speaking on behalf of NHS Providers and the NHS Confederation, assured that efforts are underway to ensure patients receive timely information and support. He reiterated that individuals should attend scheduled appointments unless specifically notified of a change by their healthcare provider.

The situation is further complicated by ongoing supply chain vulnerabilities affecting other medications. A separate, unrelated shortage of co-codamol, a commonly prescribed painkiller, is expected to last until at least June, according to the National Pharmacy Association. This adds to the challenges faced by healthcare providers in managing pain effectively.

While the NHS is actively seeking to increase supplies from four other manufacturers, the reliance on a single primary supplier – Heraeus Medical, which provides approximately three-quarters of the bone cement used in the NHS – highlights the potential risks associated with concentrated supply chains. The current disruption underscores the need for robust contingency planning and diversification of suppliers to mitigate future disruptions and ensure continuity of care for patients.

The NHS is urging patients to assume their appointments will proceed as planned unless they are directly informed of a postponement. Ongoing updates will be provided as the situation evolves, and healthcare professionals are dedicated to minimizing the impact on patient care.